SENTI BIOSCIENCES INC Share Price Today: Live Updates & Key Insights

SENTI BIOSCIENCES INC share price today is $0.91, up 2.14%. The stock opened at $0.9151 against the previous close of $0.9007, with an intraday high of $0.9151 and low of $0.86455.

SENTI BIOSCIENCES INC Share Price Chart

SENTI BIOSCIENCES INC

us-stock
To Invest in {{usstockname}}
us-stock

SENTI BIOSCIENCES INC Share Price Performance

$0.91 0.0214(2.14%) SNTI at 23 Mar 2026 03:16 PM Biotechnology
Lowest Today 0.86455
Highest Today 0.9151
Today’s Open 0.9151
Prev. Close 0.9007
52 Week High 5.10
52 Week Low 0.80
Day’s Range: Low 0.86455 High 0.9151
52-Week Range: Low 0.80 High 5.10
1 day return -
1 Week return -6.19
1 month return +7.14
3 month return -25.1
6 month return -34.05
1 year return -75.27
3 year return -26.01
5 year return -90.88
10 year return -

SENTI BIOSCIENCES INC Institutional Holdings

NEA Management Company, LLC 14.36

Nantahala Capital Management, LLC 3.38

Vanguard Group Inc 2.39

Vanguard Total Stock Mkt Idx Inv 1.40

Vanguard Institutional Extnd Mkt Idx Tr 0.64

Geode Capital Management, LLC 0.55

Abante Quant Value FI 0.50

Fidelity Extended Market Index 0.27

Jane Street Group LLC 0.15

MSOP GP, LLC 0.14

XTX Topco Ltd 0.10

Fidelity Nasdaq Composite Index 0.09

BlackRock Inc 0.09

Fidelity Total Market Index 0.08

iShares Micro-Cap ETF 0.08

Fidelity Series Total Market Index 0.07

Northern Trust Corp 0.06

Vanguard Instl Ttl Stck Mkt Idx Tr 0.05

Northern Trust Extended Eq Market Idx 0.05

NT Ext Equity Mkt Idx Fd - L 0.05

State Street Corp 0.04

Spartan Total Market Index Pool G 0.03

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.02

Blackrock Extended Mkt Fund CF 0.01

Tower Research Capital LLC 0.01

Extended Equity Market Fund K 0.01

NT Ext Equity Mkt Idx Fd - NL 0.01

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.01

1290 VT Micro Cap K 0.01

Spartan Extended Market Index Pool F 0.00

NT US Market Cap Idx Fd - L 0.00

Bank of America Corp 0.00

SBI Securities Co Ltd 0.00

Morgan Stanley - Brokerage Accounts 0.00

Armistice Capital, LLC 0.00

Barclays PLC 0.00

Citadel Advisors Llc 0.00

Citigroup Inc 0.00

Two Sigma Investments LLC 0.00

UBS Group AG 0.00

SENTI BIOSCIENCES INC Market Status

Strong Buy: 1

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

SENTI BIOSCIENCES INC Fundamentals

Market Cap 24.19 M

PB Ratio 2.9671

PE Ratio 0.0

Enterprise Value 41.97 M

Total Assets 97.84 M

Volume 189580

SENTI BIOSCIENCES INC Company Financials

Annual Revenue FY23:1787000 1.8M, FY22:4286000 4.3M, FY21:2291000 2.3M, FY20:394000 0.4M, FY19:null 0.0M

Annual Profit FY23:null 0.0M, FY22:4286000 4.3M, FY21:2291000 2.3M, FY20:394000 0.4M, FY19:null 0.0M

Annual Net worth FY23:-70552000 -70.6M, FY22:-45791000 -45.8M, FY21:-55330000 -55.3M, FY20:-20012000 -20.0M, FY19:null 0.0M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:-904000 -0.9M, Q2/2025:-1476000 -1.5M, Q1/2025:null 0.0M, Q3/2024:null 0.0M, Q2/2024:-1467000 -1.5M

Quarterly Net worth Q3/2025:-18126000 -18.1M, Q2/2025:-14733000 -14.7M, Q1/2025:-14112000 -14.1M, Q3/2024:-28866000 -28.9M, Q2/2024:-11203000 -11.2M

About SENTI BIOSCIENCES INC & investment objective

Company Information Senti Biosciences, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. Its lead product candidates utilize off-the-shelf healthy adult donor derived natural killer (NK) cells to create CAR-NK cells outfitted with gene circuit technologies in various oncology indications with unmet need. The company's product candidates also include SENTI-202, a logic gated off-the-shelf CAR-NK cell therapy for the treatment of blood cancers and relapsed/refractory hematological malignancies, including acute myeloid leukemia; and SENTI-301A, an off-the-shelf CAR-NK cell therapy for the treatment of solid tumors and hepatocellular carcinoma. In addition, it develops the tumor-associated antigen and protective antigen paired discovery platform to select and validate NOT GATE antigen candidates and identify tumor-associated antigens in cancer cells. Further, its pipeline includes preclinical programs, which comprise a solid tumor cell therapy program; and partnered programs related to gene therapies for tissue-directed targets, as well as partnered programs related to cell therapies for regenerative medicines. The company has a strategic collaboration with Celest Therapeutics (Shanghai) Co. Ltd for the clinical development of SENTI-301A to treat solid tumors. Senti Biosciences, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.

Organisation Biotechnology

Employees 34

Industry Biotechnology

CEO Dr. Timothy K. Lu M.D., Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

SENTI BIOSCIENCES INC FAQs

What is the share price of SENTI BIOSCIENCES INC today?

The current share price of SENTI BIOSCIENCES INC is $0.91.

Can I buy SENTI BIOSCIENCES INC shares in India?

Yes, Indian investors can buy SENTI BIOSCIENCES INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy SENTI BIOSCIENCES INC shares in India?

You can easily invest in SENTI BIOSCIENCES INC shares from India by:

Can I buy fractional shares of SENTI BIOSCIENCES INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of SENTI BIOSCIENCES INC?

SENTI BIOSCIENCES INC has a market cap of $24.19 M.

In which sector does SENTI BIOSCIENCES INC belong?

SENTI BIOSCIENCES INC operates in the Biotechnology sector.

What documents are required to invest in SENTI BIOSCIENCES INC stocks?

To invest, you typically need:

What is the PE and PB ratio of SENTI BIOSCIENCES INC?

The PE ratio of SENTI BIOSCIENCES INC is N/A and the PB ratio is 2.97.